Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided calculator for neonatal vancomycin, gentamicin, or amikacin dosing
ACTRN12610001038088Phase 4Terminated
- Sponsor
- The University of Auckland
- Start
- Apr 2011
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vancomycin, gentamicin and amikacin in sepsis (2 arms), sponsored by The University of Auckland. Started Apr 2011; status: terminated.
02
Drugs
vancomycingentamicinamikacin
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12610001038088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001038088.